Scarica l'app Stockscreener
1.30
2.36%
0.03
Dopo l'orario di chiusura:
1.31
0.01
+0.77%
Precedente Chiudi:
$1.27
Aprire:
$1.3
Volume 24 ore:
113.71K
Relative Volume:
0.72
Capitalizzazione di mercato:
$47.54M
Reddito:
-
Utile/perdita netta:
$-9.16M
Rapporto P/E:
-2.2807
EPS:
-0.57
Flusso di cassa netto:
$-8.75M
1 W Prestazione:
+0.00%
1M Prestazione:
-8.45%
6M Prestazione:
-5.80%
1 anno Prestazione:
+4.84%
Intervallo 1D:
$1.26
$1.30
Intervallo di 1 settimana:
$1.23
$1.35
Portata 52W:
$0.75
$1.6899
Renovorx Inc Stock (RNXT) Company Profile
Nome
Renovorx Inc
Settore
Industria
Telefono
408-800-2649
Indirizzo
2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW
Confronta RNXT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RNXT
Renovorx Inc
|
1.30 | 46.81M | 0 | -9.16M | -8.75M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Renovorx Inc Borsa (RNXT) Ultime notizie
Is RenovoRx Inc. a good long term investmentFree Stock Market Return Analysis - PrintWeekIndia
What analysts say about RenovoRx Inc. stockExtraordinary performance - PrintWeekIndia
What drives RenovoRx Inc. stock priceFree Market Dynamics Reports - jammulinksnews.com
RenovoRx Inc. Stock Analysis and ForecastFree Investment Timing Strategies - jammulinksnews.com
RenovoRx (NASDAQ:RNXT) Upgraded to Hold at Wall Street Zen - Defense World
What makes RenovoRx Inc. stock price move sharplyFree Premium Stock Market Reports - Newser
Why RenovoRx Inc. stock attracts strong analyst attentionHigh Reward Risk Balanced Trading - Newser
How RenovoRx Inc. stock performs during market volatilityFast Gains With Reduced Risk - Newser
RenovoRx to Host Second Quarter 2025 Financial Results and Business Highlights Conference Call on August 14th at 4:30 p.m. ET - BioSpace
RenovoRx to Host Second Quarter 2025 Financial Results and Business Highlights Conference Call on August 14 - Business Wire
RenovoRx (NASDAQ:RNXT) Trading Down 2.9% – Should You Sell? - Defense World
Will RenovoRx (NASDAQ:RNXT) Spend Its Cash Wisely? - Yahoo Finance
RenovoRx shareholders elect directors and approve incentive plan amendments - Investing.com
RenovoRx Stockholders Approve Key Proposals at Annual Meeting - TipRanks
Short Interest in RenovoRx, Inc. (NASDAQ:RNXT) Declines By 35.4% - Defense World
Citadel Advisors LLC Invests $49,000 in RenovoRx, Inc. (NASDAQ:RNXT) - Defense World
RenovoRX chief medical officer buys $29,399 in common stock By Investing.com - Investing.com Canada
RenovoRX chief medical officer buys $29,399 in common stock - Investing.com Australia
Insider Buying: Ramtin Agah Acquires Additional Shares of RenovoRx Inc (RNXT) - GuruFocus
RenovoRx (NASDAQ:RNXT) Stock Rating Upgraded by Wall Street Zen - Defense World
RenovoRx (NASDAQ:RNXT) Given New $11.50 Price Target at Ascendiant Capital Markets - Defense World
RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results - Yahoo Finance
Renovorx Inc Azioni (RNXT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):